The Adherence Gap: Why Osteoporosis Patients Don’t Continue With Treatment

The Adherence Gap: Why Osteoporosis Patients Don’t Continue With TreatmentA European report highlighting the gap between the beliefs of people with osteoporosis and the perceptions of their physicians

This 2005 survey, carried out for IOF by IPSOS Health, aimed to understand the reasons why women with osteoporosis do not stay on treatment. It showed that 34 per cent of women interviewed either didn’t know what the benefits of their medication were or wrongly thought there were no benefits at all. Drawbacks of treatment identified by women were predominantly related to inconvenience and side effects.

“This is extremely concerning” said Jean-Yves Reginster, Professor of Epidemiology, Public Health and Health Economics at the University of Liege, Belgium. “If we are going to have an impact on the overall burden of osteoporosis it is vital that our patients stay on therapy long term. This survey shows us that while 90 per cent of women view osteoporosis as a serious condition they don’t fully appreciate all the benefits of their treatment.”

The survey also highlighted some major communication gaps between doctors and the patients they treat.

Download the Adherence Gap Survey and Report (PDF, 1.4 MB)